Development of 225Ac- and 213Bi-labelled somatostatin analogues with improved tumour to kidney ratio for the treatment of neuroendocrine tumours
Institut | KU LEUVEN |
---|---|
Phd a commencé le | |
Phd obtenu le |
Institut | KU LEUVEN |
---|---|
Phd a commencé le | |
Phd obtenu le |